Specialists for Nodular lymphocyte predominant Hodgkin lymphoma

32 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Dieter Koerholz, MD
Rare Disease / Clinical Research
Universitaetsklinikum Giessen und Marburg
QC-verified PI×3
Frank G. Keller, MD
Rare Disease / Clinical Research
Emory Children's Center - Atlanta
QC-verified PI×1
Ranjana H Advani, MD, MD
Rare Disease / Clinical Research
Stanford University
STANFORD, CA
PI×2
Alex F Herrera
Rare Disease / Clinical Research
City of Hope Medical Center
PI×7
Andreas Engert, MD
Rare Disease / Clinical Research
University of Cologne
PI×1
Richard T Hoppe, MD, MD
Rare Disease / Clinical Research
Stanford University
LUTHERVILLE TIMONIUM, MD
PI×1
Kristie Blum, MD, M.D
Rare Disease / Clinical Research
Ohio State University
ATLANTA, GA
PI×4
Ajay Major, MD, MBA, MD, MBA
Rare Disease / Clinical Research
University of Colorado, Denver
AURORA, CO
PI×1
Raphael E Steiner, MD
Rare Disease / Clinical Research
University of Texas MD Anderson Cancer Center LAO
NEW YORK, NY
PI×2
Andreas Engert, Prof.
Rare Disease / Clinical Research
University Hospital of Cologne
PI×5
Ryotaro Nakamura
Rare Disease Specialist
City of Hope Medical Center
Duarte, California
PI×6
Jamie Flerlage, MD, MS, MD
Rare Disease / Clinical Research
University of Rochester
ROCHESTER, NY
PI×1
Mark Kirschbaum, MD
Rare Disease / Clinical Research
City of Hope Medical Center
HERSHEY, PA
PI×4 2
Debra Friedman
Rare Disease / Clinical Research
Children's Oncology Group
PI×1
Peter Johnson, MD
Rare Disease / Clinical Research
University Hospital Southampton NHS Foundation Trust
PI×2
Anna Jones, PhD
Rare Disease / Clinical Research
St. Jude Children's Research Hospital
PI×1
Kristie Blum, M.D
Rare Disease / Clinical Research
Cancer and Leukemia Group B
ATLANTA, GA
PI×5
Leo Gordon, MD
Rare Disease / Clinical Research
Northwestern University
PI×3 1
Terzah Horton, M.D
Rare Disease / Clinical Research
Children's Oncology Group
HOUSTON, TX
PI×2
Tanya Trippett, MD, MD
Rare Disease / Clinical Research
Memorial Sloan Kettering Cancer Center
NEW YORK, NY
PI×7
Valerie Crabtree, PhD, PTA 4209
Rare Disease / Clinical Research
St. Jude Children's Research Hospital
STARKVILLE, MS
PI×2
Matthew Rees, MD, MD
Rare Disease / Clinical Research
St. Jude Children's Research Hospital
ROCHESTER, MN
PI×1
Patrick A. Thompson, MD
Rare Disease / Clinical Research
Baylor College of Medicine
PI×2
Beth Christian, MD
Rare Disease / Clinical Research
Ohio State University
PI×3
Burton E Appel
Rare Disease Specialist
Children's Oncology Group
Birmingham, Alabama
PI×1 5
Kirit Ardeshna
Rare Disease / Clinical Research
University College London Hospitals
PI×1
Rakhee Vaidya, PA-C
Rare Disease / Clinical Research
Wake Forest University Health Sciences
NEW YORK, NY
PI×1 7
Ralph M. Meyer, D.C
Margaret and Charles Juravinski Cancer Centre
GARLAND, TX
QC-verified PI×1
Alexandra Stefanovic, MD
University of Miami Sylvester Comprehensive Cancer Center
DURHAM, NC
QC-verified PI×1
Peter Cole
Rutgers Cancer Institute of New Jersey
QC-verified PI×1
Peter J. Hoskin
Mount Vernon Cancer Centre at Mount Vernon Hospital
QC-verified PI×1
Kara Kelly
Herbert Irving Comprehensive Cancer Center
QC-verified PI×3

More about Nodular lymphocyte predominant Hodgkin lymphoma